Abstract
Aim. To analyze the data provided by advanced scientific research focused on prescription of menopausal hormone therapy (MHT) aimed at preventing cardiovascular disorders in the post-reproductive period.
Methods. Analytical review of domestic and foreign papers on the topic, including using PubMed, Elseviewer, Cochrane library, Elibrary databases.
Conclusions. Despite the fact that the issue of prevention and treatment of cardiovascular disorders attracts particular attention of global healthcare, CVDs still rank first in the world as the cause of deaths. In menopausal women, hypoestrogenism is among major pathogenetic links of cardiac abnormalities. To increase adherence of peri- and postmenopausal women to early diagnosis, general practitioners should give due consideration to referral of such women to obstetricians-gynecologists for timely correction of estrogen deficiency. It is also necessary to further study the issue in order to identify early diagnostic predictors of cardiovascular disorders.
Key words: menopausal syndrome, menopause, climacterium, cardiovascular disorders, MHT.
For citation:Mazitova M.I., Mardieva R.R., Faustova K.V. Role of menopausal hormone therapy in the issues of preventing cardiovascular disorders in women in their post-reproductive stage. Clinical review for general practice. 2023; 4 (10): 95–102 (In Russ.). DOI: 10.47407/kr2023.4.10.00348
All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.